The timing of a simple, standard part of childbirth could mean the difference between life and death for premature babies, a pair of new evidence…
Read on
Retatrutide, an experimental weight-loss drug that could compete against blockbusters Wegovy and Zepbound, may work wonders for obese folks with liver disease, new research shows.…
Read on
Air pollution could be harming the development of children, reaching into the womb to alter their healthy growth, a new study reports. Researchers say certain…
Read on
TUESDAY, Nov. 14, 2023 (Healthday News) — There is nothing worse for your heart than sitting, a new study confirms. “The big takeaway from our…
Read on
MONDAY, Nov. 13, 2023 (Healthday News) — In a finding that could change the landscape of heart disease care, the wildly popular weight-loss drug Wegovy…
Read on
Women and their doctors have long known that taking birth control pills can elevate the risk for a blood clot. Now, some good news: That…
Read on
A kinder, more thoughtful workplace can lead to better heart health among older employees, a new study finds. Older workers’ heart health risk factors decreased…
Read on
The U.S. Food and Drug Administration has received at least three reports of people being hospitalized after taking counterfeit versions of the wildly popular weight-loss…
Read on
An old scourge, syphilis, is returning with a vengeance in the United States, affecting not only adults but also the most vulnerable — newborns. Rates…
Read on
When doctors advise patients to lose weight, an optimistic approach is more likely to get results. Researchers found that patients were more likely to participate…
Read on
TUESDAY, Nov. 7, 2023 (HealthDay News) – A new study provides deeper insight into the safety of COVID-19 vaccines for people planning to become pregnant.…
Read on
WEDNESDAY, Nov. 1, 2023 Following nearly two decades of decline, U.S. infant death rates edged up by 3% in 2022, new provisional government numbers reveal.…
Read on
